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S.A.AR86, a member of the Sindbis group of alphaviruses, is neurovirulent in adult mice and has a unique
threonine at position 538 of nsP1; nonneurovirulent members of this group of alphaviruses encode isoleucine.
Isoleucine was introduced at position 538 in the wild-type S.A.AR86 infectious clone, ps55, and virus derived
from this mutant clone, ps51, was significantly attenuated for neurovirulence compared to that derived from
ps55. Intracranial (i.c.) s55 infection resulted in severe disease, including hind limb paresis, conjunctivitis,
weight loss, and death in 89% of animals. In contrast, s51 caused fewer clinical signs and no mortality.
Nevertheless, comparison of the virus derived from the mutant (ps51) and wild-type (ps55) S.A.AR86 molec-
ular clones demonstrated that s51 grew as well as or better than the wild-type s55 virus in tissue culture and
that viral titers in the brain following i.c. infection with s51 were equivalent to those of wild-type s55 virus.
Analysis of viral replication within the brain by in situ hybridization revealed that both viruses established
infection in similar regions of the brain at early times postinfection (12 to 72 h). However, at late times
postinfection, the wild-type s55 virus had spread throughout large areas of the brain, while the s51 mutant
exhibited a restricted pattern of replication. This suggests that s51 is either defective in spreading throughout
the brain at late times postinfection or is cleared more rapidly than s55. Further evidence for the contribution
of nsP1 Thr 538 to S.A.AR86 neurovirulence was provided by experiments in which a threonine residue was
introduced at nsP1 position 538 of Sindbis virus strain TR339, which is nonneurovirulent in weanling mice.
The resulting virus, 39ns1, demonstrated significantly increased neurovirulence and morbidity, including
weight loss and hind limb paresis. These results demonstrate a role for alphavirus nonstructural protein genes
in adult mouse neurovirulence.
The outcome of experimental Sindbis virus infection is de-
pendent on both the genetics of the virus and the age of the
rodent host. In suckling mice, Sindbis virus infection results in
a shock-like disease with high levels of proinflammatory cyto-
kines and 100% mortality in the absence of encephalitis (37,
38). Introduction of attenuating mutations into the Sindbis
virus genome abrogates the shock-like disease, extends the
average survival time (AST), and, depending on the degree of
attenuation, decreases mortality. With the less virulent Sindbis
strains, an encephalitis is evident (15). In contrast to infection
of suckling mice, animals greater than 10 to 14 days of age are
completely resistant to Sindbis virus and the group of alphavi-
ruses most closely related to it, even when virus is administered
by the intracranial (i.c.) route (reviewed in reference 12).
S.A.AR86 is a notable exception in that it remains neuroviru-
lent in adult animals (33).
Sequence comparisons have placed the Sindbis-group vi-
ruses into two categories (28). One subgroup contains the
AR339 strain of Sindbis, which was originally isolated in Egypt
(36); while the second subgroup includes S.A.AR86 and Gird-
woodS.A., which were isolated in South Africa (25, 33, 42); and
Ockelbo, which was identified in Sweden (34). Of the viruses
within the second subgroup, only S.A.AR86 is neurovirulent
in weanling and adult mice, causing 90 to 100% mortality in
mice of any age (33, 42). The existence of adult neurovirulent
and nonneurovirulent strains makes Sindbis-group viruses par-
ticularly useful for studying alphavirus neurovirulence. The
complete nucleotide sequence has been obtained for the non-
neurovirulent viruses AR339 (29), Ockelbo (32), and Gird-
woodS.A. (33), as well as S.A.AR86 (33). This allows identifi-
cation of changes which are unique to the neurovirulent virus
by direct comparison of the nucleotide and amino acid se-
quences. Furthermore, full-length infectious cDNA clones ex-
ist for S.A.AR86, as well as nonneurovirulent strains, such as
TR339 (14). Therefore, the contribution of single-amino-acid
loci to the adult neurovirulence phenotype can be evaluated by
substituting specific codons from the nonneurovirulent virus
into the neurovirulent virus and vice versa.
Previous studies of adult neurovirulence of Sindbis-group
viruses have utilized NSV, a strain of Sindbis isolated after
alternating i.c. passage of AR339 in suckling and weanling
mice (7). The i.c. inoculation of 3- to 4-week-old mice with
NSV results in 100% mortality, but unlike S.A.AR86, NSV
causes decreased mortality in older mice (7). Studies with NSV
found that the E1 and E2 glycoproteins play an important role
in adult neurovirulence (24). Of particular importance is a
histidine at position 55 of the E2 glycoprotein, which is essen-
tial for NSV neurovirulence (24). The mechanism by which E2
His 55 and other determinants within the glycoproteins con-
tribute to neurovirulence has not been completely determined,
although viruses containing E2 His 55 exhibit increased repli-
cation in cultured cells and are able to overcome bcl2 expres-
sion to kill mature neurons (11, 21, 22, 39). Though the viral
glycoproteins certainly play an important role in adult neuro-
virulence, it is clear that other regions of the viral genome also
contribute to this phenotype. The viral 59 untranslated region
modulates the neurovirulence of the SVNI strain of Sindbis
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virus in adult rats (16). Chimeric viruses, in which the glyco-
proteins are derived from the NSV strain and the nonstructural
proteins are derived from a nonneurovirulent strain, exhibit
only 44% mortality in 4-week-old mice, while NSV causes
100% mortality (24). Furthermore, S.A.AR86, which is fully
neurovirulent in adult mice regardless of the animal’s age, does
not encode a histidine at position 55 of the E2 glycoprotein,
suggesting that determinants other than E2 His 55 can affect
the neurovirulence phenotype (33).
The contribution of the viral nonstructural proteins to neu-
rovirulence has largely gone unstudied. Alphaviruses encode
four nonstructural proteins, which are rapidly expressed after
infection and comprise the viral replicase (reviewed in refer-
ence 35). With one exception, the nonstructural proteins of the
Sindbis-group viruses are translated from the genomic RNA as
two polyproteins, P123 and P1234. Termination at an opal
termination codon between nsP3 and nsP4 results in produc-
tion of P123, while translational readthrough to nsP4 results in
P1234 (reviewed in reference 35). The exception to this rule is
S.A.AR86, which encodes a cysteine rather than the opal ter-
mination codon (33) and produces only the P1234 polyprotein.
These polyproteins are then processed into intermediate cleav-
age products and the individual nonstructural proteins by a
papain-like thiol protease, which is located in the C-terminal
half of nsP2 (reviewed in reference 35). Each of the nonstruc-
tural proteins is required for efficient RNA synthesis. Specific
functions have been assigned to nsP1, nsP2, and nsP4. nsP1
acts as both a methyltransferase and guanyltransferase (27,
31), while nsP2 is thought to act as an RNA helicase and
encodes the protease responsible for processing of the non-
structural polyprotein (4, 6, 10, 35). nsP4 acts as the core RNA
polymerase (9, 13, 35). No specific function has been assigned
to nsP3 (reviewed in reference 35), although the finding that
nsP3 is a phosphoprotein (23) suggests a possible regulatory
role. In addition to the individual nonstructural proteins, the
polyprotein precursor, P123, as well as the intermediate cleav-
age products, plays a role in regulating viral RNA synthesis
(reviewed in reference 35).
In this study, we report the identification of a single amino
acid at position 538 within the nsP1 protein that plays an
important role in S.A.AR86 neurovirulence for adult mice.
S.A.AR86 contains a unique threonine at nsP1 538, while the
nonneurovirulent Sindbis-group viruses encode an isoleucine.
Conversion of the threonine to isoleucine in S.A.AR86 re-
sulted in attenuation of neurovirulence in adult mice. The
mutant S.A.AR86 clone grew as well as or better than the
wild-type virus both in vivo and in vitro. However, the mutant
displayed a defect in spreading throughout the brain at late
times during infection. Further evidence for the contribution
of nsP1 Thr 538 to neurovirulence was provided by the intro-
duction of a threonine codon at nsP1 538 of a nonneuroviru-
lent Sindbis-group virus. This resulted in a partially neuroviru-
lent virus which caused significantly more disease in 18- to
21-day-old mice.
MATERIALS AND METHODS
Viruses and virus stocks. Names of plasmids containing viral cDNA have the
prefix “p,” while virus derived from the clone does not have the “p” designation;
i.e., s55 denotes virus derived from the plasmid ps55. Clone ps55 represents a
fully virulent infectious clone of S.A.AR86, which has been described previously
(33). Virus derived from this clone exhibits all of the biologic characteristics of
the natural S.A.AR86 isolate (33, 42). Clone ps51 represents an intermediate
sequence used in the construction of the fully neurovirulent S.A.AR86 clone
ps55 (33). ps51 differs from clone ps55 at a single nucleotide (position 1672),
where ps55 has cytidine and ps51 has thymidine. This nucleotide difference
results in a single amino acid change at position 538 of nsP1, where ps51 encodes
an isoleucine and ps55 encodes a threonine found in natural S.A.AR86 isolates
(33). Clone pTR339 represents a consensus sequence clone based on the original
Sindbis virus AR339 strain, in which cell culture-derived mutations have been
corrected (14, 26). Clone p39ns1 was constructed by replacing the thymidine at
position 1672 of pTR339 with cytidine by PCR megaprimer mutagenesis (30).
This resulted in p39ns1 encoding a threonine at nsP1 position 538, rather than
the isoleucine found in pTR339. Introduction of the mutation was confirmed by
sequencing at the University of North Carolina at Chapel Hill Automated DNA
Sequencing Facility with a model 373A DNA sequencer (Applied Biosystems).
Virus stocks were made in the following manner. Plasmids ps55 and ps51 were
linearized with XbaI (New England Biolabs), while pTR339 and p39ns1 were
linearized with XhoI (New England Biolabs). Full-length transcripts were pro-
duced with SP6 specific Maxiscript in vitro transcription kits (Ambion). Tran-
scripts were electroporated into BHK-21 cells grown in minimal essential me-
dium (10% fetal calf serum [Gibco], 10% tryptose phosphate broth [Sigma], 1%
glutamine [Biofluids]). Supernatants were harvested and aliquoted 24 to 27 h
after electroporation, and virus was titrated on BHK-21 cells as previously
described (33).
Animal studies. Specific-pathogen-free female CD-1 mice were obtained from
Charles River Breeding Laboratories (Raleigh, N.C.). Animal housing and care
were in accordance with all University of North Carolina at Chapel Hill and
Institutional Animal Care and Use Committee guidelines. Six-week-old mice
were anesthetized with Metofane (Schering-Plough) prior to i.c. inoculation with
500 or 103 PFU of s55 or s51 diluted in phosphate-buffered saline (PBS [pH 7.4]),
supplemented with 1% donor calf serum (DCS) (Gibco). Similar results were
obtained with either dose of virus. Mock-infected mice received diluent alone.
For experiments with TR339 and 39ns1, 18- to 21-day-old mice were used. Mice
were scored daily for clinical signs by visual inspection and body weight. Severely
ill animals were euthanized. In separate experiments, mice were anesthetized
with Metofane at various times postinfection, sacrificed by exsanguination, and
perfused with PBS. The left hemisphere of the brain was then removed for
titration of virus load by plaque assay. Alternatively, following exsanguination,
mice were perfused with 4% paraformaldehyde, and the entire brain was re-
moved for in situ hybridization studies, as previously described (2).
Cell culture. BHK-21 cells were maintained at 37°C in alpha minimal essential
medium (Gibco) supplemented with 10% DCS, 10% tryptose phosphate broth,
and 0.29 mg of L-glutamine per ml. Plaque assays of virus stocks and in vitro
growth curve experiments were performed as previously described (33). For in
vivo growth curves, mice were sacrificed at various times postinfection and
perfused with PBS (pH 7.4), and the left hemisphere of the brain was suspended
as a 25% homogenate in PBS (pH 7.4) supplemented with 1% DCS and Ca21-
Mg21 Plaque assays were then performed as described previously (33).
In vitro growth curves were determined as follows. BHK-21 cells were plated
at 105 cells/well in 24-well plates (Sarstedt) for 14 to 16 h at 37°C. Medium was
removed, and wells were infected with virus in triplicate at a multiplicity of
infection (MOI) of 5.0. Cells were incubated at 37°C for 1 h. Wells were then
washed three times with 0.5 to 1 ml of room temperature PBS supplemented with
1% DCS and Ca21-Mg21. One milliliter of growth medium was then added to
each well, and cells were incubated at 37°C. Samples of supernatant were re-
moved at various time points, with an equal volume of fresh medium added to
maintain a constant volume within each well. Samples were frozen at 280°C until
analysis by plaque assay.
In situ hybridization. Hybridizations were performed with a 35S-UTP-labeled
S.A.AR86-specific riboprobe derived from pDS-45. Clone pDS-45 was con-
structed by amplifying a 707-bp fragment from ps55 by PCR with primers 7241
(59CTGCGGCGGATTCATCTTGC-39) and SC-3 (59-CTCCAACTTAAGTG-
39). The resulting 707-bp fragment was purified by using Gene Clean (Bio 101,
Inc., La Jolla, Calif.), digested with HhaI, and cloned into the SmaI site of pSP72
(Promega). Clone pDS-45 was linearized with EcoRV and transcribed in vitro
with a Maxiscript SP6 transcription kit (Ambion) in the presence of 35S-UTP to
yield a riboprobe approximately 500 nucleotides in length, of which 445 nucle-
otides were complementary to S.A.AR86 nucleotides 7371 to 7816. This includes
the last 187 nucleotides of the nsP4 gene, the 26S promoter region, and the first
209 nucleotides of the capsid gene. A riboprobe specific for the influenza virus
strain PR-8 hemagglutinin gene was used as a control probe for nonspecific
binding (3). The S.A.AR86 riboprobe was hybridized to tissues from PBS-inoc-
ulated mice as an additional control for nonspecific binding. The in situ hybrid-
izations were performed according to the method of Charles et al. (2) by using
25 ml of probe/slide at 5 3 104 cpm/ml.
RESULTS
A single amino acid change in nsP1 attenuates a S.A.AR86
infectious clone for neurovirulence in adult mice. It is well
established that changes within the 59 untranslated region and
glycoprotein genes can affect alphavirus virulence (5, 16, 17, 24,
26). However, the role of alphavirus nonstructural proteins in
neurovirulence has not been evaluated. Identification of mo-
lecular determinants of S.A.AR86 neurovirulence in adult
mice was facilitated by the existence of molecular clones de-
rived from a natural isolate of S.A.AR86 (33). One clone, ps55,
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is identical in coding sequence to the natural S.A.AR86 isolate.
Furthermore, virus derived from ps55 exhibits all of the phe-
notypic characteristics of natural S.A.AR86 isolates, including
neurovirulence in adult mice (33). Additional S.A.AR86
clones, containing mutations at various sites within the non-
structural genes, were made during the construction of the
wild-type ps55 clone (D. A. Simpson and R. E. Johnston,
unpublished observations). One mutant, clone ps51, was of
particular interest. Clone ps51 is isogenic with ps55, except for
a single amino acid change of threonine to isoleucine at posi-
tion 538 of nsP1. This change was striking, since isoleucine at
nsP1 538 is found in the nonneurovirulent Sindbis-group vi-
ruses (29, 32, 33), including GirdwoodS.A. and Ockelbo, which
are closely related to S.A.AR86, but are not neurovirulent in
adult animals (25, 32, 33; D. A. Simpson and R. E. Johnston,
unpublished observations). Furthermore, the threonine at po-
sition 538 represents the only amino acid change within nsP1
that is unique to S.A.AR86 as compared to the nonneuroviru-
lent Sindbis-group viruses.
Neurovirulence of s51 and s55 was evaluated by i.c. infection
of 6-week-old female CD-1 mice. An i.c. infection with 500
PFU of s55 caused severe disease, including loss of 30 to 40%
of body weight, moderate to severe hind limb paresis, conjunc-
tivitis, and limbic disorders, such as loss of balance and tremors
(Fig. 1 and Table 1). Similar results were found when mice
were infected with 1,000 PFU of s55. Furthermore, 89% of
mice infected with either 500 or 1,000 PFU of s55 died, with an
AST of 7.0 6 2.0 days (Table 1). In contrast, mice infected with
either 500 or 1,000 PFU of s51 exhibited less severe disease
signs and no mortality (Fig. 1 and Table 1). s51 caused a 20 to
25% drop in body weight, conjunctivitis in only 1 of 15 animals,
no loss of motor control, and a milder degree of paresis than
s55 (Fig. 1 and Table 1). s51-infected mice eventually recov-
ered the lost body weight, although paresis persisted in some
animals for up to 3 months (data not shown). Therefore,
changing the threonine found in wild-type S.A.AR86 (clone
s55) to isoleucine found in the nonneurovirulent Sindbis-group
viruses resulted in attenuation of S.A.AR86 neurovirulence.
In vitro and in vivo growth kinetics of s51 and s55. It was
possible that the attenuation of s51 reflected a general defect
in replication compared to the wild-type s55 virus. Therefore,
the ability of the two viruses to grow in BHK-21 cells was
compared. BHK cells were infected with either virus at an
MOI of 5.0, and virus titers in the supernatant were evaluated
over time. Both viruses grew to roughly equivalent titers with
the same kinetics (Fig. 2). In fact, s51 titers were always as high
as or higher than s55 titers. At 24 h postinfection, s55 plaques
had an average diameter of 0.36 6 0.1 mm, while s51 plaques
had an average diameter of 0.51 6 0.17 mm (P , 0.001;
Student’s t test, two tailed). These results suggest that s51
grows at least as well as s55 in vitro and may actually have a
slight growth advantage.
Since s51 grew as well as or better than s55 in vitro, the
ability of the two viruses to replicate within the brains of
infected animals was evaluated. Six-week-old female CD-1
FIG. 1. Virus derived from S.A.AR86 clone ps51 causes less morbidity and
mortality than virus derived from the wild-type clone ps55. Six-week-old female
CD-1 mice were infected i.c. with 500 PFU of the wild-type s55 or the mutant s51.
(A) Mice were monitored for weight loss as an indicator of morbidity. Mouse
weight is plotted as percentage of starting body weight over time. Data represent
the mean percentage from five animals per group (s55 and s51) or two animals
(mock). E, s51-infected mice; Œ, s55-infected mice; 1, mock-infected mice.
Error bars represent the standard error. The data shown represent results from
one of three comparable experiments. (B) Percentage of mice surviving over time
after s51 or s55 infection. There were 7 mock-infected mice, 15 s51-infected
mice, and 19 s55-infected mice. The data shown are pooled from three separate
experiments.
FIG. 2. s51 and s55 grow at equivalent rates in vitro. BHK-21 cells were
infected in triplicate with the viruses s51 (V) and s55 (Œ) at an MOI of 5.0. After
1 h of infection at 37°C, cells were washed three times with room temperature
PBS (1% DCS), and 1 ml of growth medium was placed on the cells. One
hundred microliters of supernatant was removed for titration by plaque assay at
the indicated times. At the time of harvest, the sample volume removed was
replaced with fresh media. Samples were titrated by plaque assay on BHK-21
cells. The data shown are from one of three representative experiments. Each
data point represents the mean titer 6 standard error.
TABLE 1. Percentage of mice with clinical signs following
s55 or s51 infection
Clinical sign






Hind limb paresis 100 100
Severe paresis or paralysis 79 7
Mortality 89 0
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mice were inoculated i.c. with 103 PFU of s55 or s51, and the
levels of infectious virus within the brain were assessed by
plaque assay at intervals ranging from 3 to 144 h postinfection.
Similar to the in vitro growth curves, s51 grew to levels which
were equivalent to those of s55 in the brain (Fig. 3). These
results demonstrate that attenuation of s51 cannot be ex-
plained by a simple defect in viral replication, either in vitro or
within the infected brain.
Localization of s51 and s55 infection within the brain at
early and late times postinfection. Since s51 was attenuated for
neurovirulence, but grew in brain tissue to titers equivalent to
that of wild-type s55, the neuropathology of these viruses was
evaluated at various times postinfection. Six-week-old CD-1
mice were inoculated i.c. with 103 PFU of s55 or s51. Mice
were sacrificed at times ranging from 12 to 144 h postinfection,
at which point, they were perfused with 4% paraformaldehyde,
and brain sections were evaluated for the presence of viral
RNA by in situ hybridization with S.A.AR86-specific ribo-
probes. Both viruses exhibited similar patterns of replication at
early times (12 to 72 h) postinfection. Focal areas of viral
infection were observed within the hippocampus at 12 to 24 h
postinfection for both s51 and s55 (Fig. 4A and B). However,
at late times postinfection, the two viruses exhibited dramati-
cally different patterns of growth in the brain. By 144 h postin-
fection, s55 had spread throughout the brain, with large areas
of in situ signal particularly prevalent in the cortex (Fig. 4E).
s51 infected the same regions of the brain as s55; however,
areas of s51 infection remained more focal than s55-infected
areas (Fig. 4F). These results suggest that s51 and s55 estab-
lished infection in a similar manner. However, s51 was pre-
vented from spreading beyond focal areas of infection, while
the wild-type s55 virus spread throughout the brain at late
times postinfection. Alternatively, both viruses may spread
throughout the brain equivalently, but s51 may have been
cleared from the brain, while s55 infection progressed until the
death of the host.
Introduction of a threonine at nsP1 538 of a nonneuroviru-
lent virus. The comparison of s55 and s51 strongly suggested
that nsP1 Thr 538 was associated with neurovirulence in adult
mice. This hypothesis was tested further by introducing nsP1
Thr 538 into Sindbis virus clone TR339 (14, 26). The resulting
virus, 39ns1, was viable as determined by growth in tissue
culture, with 39ns1 growing at a similar rate to the wild-type
TR339 virus (Fig. 5). At 24 h postinfection TR339 plaques had
an average diameter of 0.61 6 0.15 mm, while 39ns1 plaques
had an average diameter of 0.37 6 0.07 mm (P , 0.001,
Student’s t test, two tailed). Following i.c. inoculation with 103
PFU of TR339, 18- to 21-day-old mice exhibited only mild
disease signs, as shown by a slight lag in weight gain compared
to mock-infected animals (Fig. 6). Three out of 18 TR339-
infected mice did show signs of mild hind limb paresis involv-
ing weakness in one hind limb, while the remaining 15 mice
exhibited no signs of paresis. In contrast, 39ns1 infection led to
a more severe disease, with mice exhibiting a transient loss in
body weight (Fig. 6), as well as paresis in one or both hind
limbs in 21 of 22 infected animals. Furthermore, 3 of 22 39ns1-
infected mice succumbed to infection with an AST of 8.3 days.
The ability of threonine at nsP1 538 to cause increased neu-
rovirulence in a normally nonneurovirulent genetic back-
ground strongly suggests that nsP1 Thr 538 is a major deter-
minant of S.A.AR86 neurovirulence in adult mice. However,
since 39ns1 did not cause 100% mortality in infected mice, it is
likely that other determinants in the S.A.AR86 genome also
contribute to the adult neurovirulence phenotype.
DISCUSSION
The results presented here are relevant not only to the
neurovirulence of Sindbis-group alphaviruses in adult mice,
but may have general application to the pathogenesis of arbo-
virus-mediated encephalitis. Reciprocal genetic changes were
used to demonstrate that the amino acid residue at nsP1 538
is an important determinant of neurovirulence in the adult
mouse model. In one case, the nsP1 538 residue character-
istic of nonneurovirulent Sindbis viruses was substituted for
the wild-type residue in a neurovirulent virus, S.A.AR86.
The result was a dramatic decrease in the neurovirulence of
S.A.AR86. In the reciprocal experiment, the S.A.AR86 residue
was introduced into the Sindbis background by using the
pTR339 clone, resulting in a significant increase in the neuro-
virulence of this virus for older animals. These results dem-
onstrate that nsP1 538 plays an important role in the adult
neurovirulence phenotype of S.A.AR86 and provide direct ev-
idence that the viral nonstructural genes can contribute to
alphavirus neurovirulence.
The neurovirulent NSV strain replicates to higher titers
within the brain than nonneurovirulent viruses (11, 40), raising
the possibility that s51 was attenuated due to a general de-
crease in replication within the central nervous system or an
inability to replicate effectively within certain cell types or
regions of the brain. However, s51 and s55 grew to similar
levels within the brain (Fig. 3). Furthermore, while in situ
hybridization for viral transcripts did not allow detailed iden-
tification of individual cell types, s51 and s55 appeared to
replicate within similar regions and cell types within the brain
(Fig. 4). At early times postinfection, cells within the hip-
pocampus were infected, while both viruses spread to other
regions of the brain in a similar manner during early and
intermediate times postinfection (Fig. 4). It was only at late
stages of the disease that s51 differed greatly from s55. By day
5 postinfection, s51 and s55 replication was observed in the
same regions of the brain. However, s55 infected large areas,
while s51 was restricted to focal areas of replication within
these regions (Fig. 4). It is interesting to note that while sig-
nificant differences between s51 and s55 replication were ob-
served within the brain at late times postinfection by in situ
FIG. 3. s51 and s55 grow with equivalent kinetics in the brains of infected
mice. Six-week-old female CD-1 mice were infected i.c. with 103 PFU of s51 or
s55. Mice were sacrificed by exsanguination at 12, 24, 48, 72, 96, 120, and 144 h
postinfection and perfused with PBS (pH 7.4). The left hemisphere of each brain
was removed and placed in three volumes of PBS (1% DCS, Ca21-Mg21).
Samples were frozen and thawed before homogenization and titration by plaque
assay on BHK-21 cells. Each data point represents the mean titer 6 the standard
error. E, s51; Œ, s55. n 5 6 to 12 animals for each time point from three pooled
experiments.
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hybridization (Fig. 4), the plaque assay showed similar levels of
s51 and s55 within the brain at all time points assayed (Fig. 3).
However, while viral titers measured by plaque assay were
falling for both viruses by day 5 postinfection, in situ hybrid-
ization clearly showed increased levels of s55 signal within
the brain at day 5. This may reflect the production of anti-
S.A.AR86 antibody by the infected animals at late times
postinfection. The presence of antibody might decrease the
amount of virus within the brain that was detectable by plaque
assay, while not affecting intracellular viral replication.
The S.A.AR86 nonstructural proteins are produced as a
single polyprotein, which is cleaved to produce the individual
nonstructural proteins, as well as cleavage intermediates, that
comprise the viral RNA replicase. nsP1 position 538 lies within
the cleavage site between nsP1 and nsP2, and changes within
this region may affect processing of the nonstructural proteins
(reviewed in reference 35). With this in mind, our laboratory is
currently investigating the effects of Thr or Ile at nsP1 538 on
the cleavage kinetics of the viral nonstructural protein precur-
sor P1234. Alteration in nonstructural protein cleavage could
have several downstream effects that alter neurovirulence.
Given the role that different ratios of the nonstructural protein
precursors, cleavage intermediates, and mature nonstructural
proteins have in regulating viral RNA synthesis (18–20), it is
possible that changing the threonine to isoleucine at this po-
sition might have a positive or negative effect on viral RNA
replication and viral growth. In vitro and in vivo growth curves
demonstrated that s51 grew at a similar rate to virus derived
from the wild-type s55 clone (Fig. 2 and 3), while 39ns1 and
TR339 also grew at similar rates. However, it is still possible
that the presence of Ile or Thr at nsP1 538 altered viral RNA
synthesis without overtly affecting viral yield. In support of this,
FIG. 4. In situ hybridization to localize sites of infection by s55 or s51. Six-week-old female CD-1 mice were infected i.c. with 103 PFU of s51 (B, D, and F) or s55
(A, C, and E). At 12, 24, 48, 72, 96, 120, and 144 h postinfection, mice were exsanguinated and perfused with 4% paraformaldehyde in PBS (pH 7.4). Brains were divided
sagitally down the midline, embedded in paraffin, and sectioned at 5 mm/section. Sections were subjected to in situ hybridization with riboprobes specific for S.A.AR86.
Nonspecific binding controls consisted of sections from mock-infected mice probed with the S.A.AR86-specific riboprobe or sections from infected mice probed with
a riboprobe specific for influenza virus strain PR/8 hemagglutinin. No specific signal was observed with either of these control groups. Shown are representative sections
at 24 (A and B), 72 (C and D), and 144 (E and F) h. There were three mice per group per time point. The data shown are from one of two comparable experiments.
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s51(nsP1 538 Ile) plaques were larger than those of s55 (nsP1
538 Thr), while 39ns1 (nsP1 538 Thr) produced smaller
plaques than TR339 (nsP1 538 Ile). Experiments are currently
under way to evaluate the effects of Thr or Ile at nsP1 538 on
synthesis of the viral negative strand, positive strand, and sub-
genomic RNAs. Alternatively, the presence of Thr versus Ile at
nsP1 538 might alter the interaction of nsP1 or one of its
precursors with host cell factors, which could have downstream
effects on survival of the infected cell or induction of the
antiviral immune response. Precedence for this with Sindbis-
group viruses is provided by the ability of histidine at position
55 of the E2 glycoprotein to overcome bcl-2-mediated protec-
tion of cells from virus-induced apoptosis in vitro (41). Fur-
thermore, changes in the 3A protein of foot-and-mouth dis-
ease virus affect the ability of the virus both to replicate in
bovine cells and to cause disease in cattle (1). Therefore, fur-
ther analysis of whether s51 and s55 differ in their ability to kill
neurons or other cell types, as well as the in-depth character-
ization of the antiviral immune response following infection
with either s51 or s55, may provide insight into the mecha-
nism(s) by which nsP1 538 contributes to neurovirulence.
There is precedent in nature for alphavirus genes other than
those coding for the glycoproteins contributing to neuroviru-
lence. Western equine encephalitis virus (WEE) is thought to
have originated through a recombination event between East-
ern equine encephalitis virus (EEE) and a Sindbis-like virus
(8). This resulted in the glycoproteins of WEE being derived
from the Sindbis-like virus and the nonstructural and capsid
genes from EEE. Since Sindbis-group viruses are not associ-
ated with encephalitis in humans, this suggests that the molec-
ular determinants of WEE neurovirulence might map to the
EEE-derived sequences in the nonstructural and capsid genes.
Further evaluation of this possibility may shed additional light
on viral determinants of alphavirus neurovirulence.
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